The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment. (Q48424823)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Ana M Basso

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Kelly B Gallagher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Kaitlin E Browman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Gerard B Fox

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Karla U Drescher

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Gerhard Gross

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Michael W Decker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Lynne E Rueter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Min Zhang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

9 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

number of pages

11

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17093979%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00213-006-0577-y

21 December 2019

exact match

0 references

cites work

A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0577-Y

Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0577-Y

Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone

21 January 2018

1 reference

12 December 2020

Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride

1 reference

12 December 2020

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

12 December 2020

Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice

1 reference

12 December 2020

Neuroleptic dysphoria: towards a new synthesis

1 reference

12 December 2020

Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues

1 reference

12 December 2020

Long-term treatment of mood disorders in schizophrenia

1 reference

12 December 2020

Glutamate release in the nucleus accumbens is involved in behavioral depression during the PORSOLT swim test

1 reference

12 December 2020

Subjective experience and mental side-effects of antipsychotic treatment.

1 reference

12 December 2020

Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria

1 reference

12 December 2020

Effect of imipramine in the "learned helplessness" model of depression in rats is not mimicked by combinations of specific reuptake inhibitors and scopolamine

1 reference

12 December 2020

Depression in schizophrenia: recognition and management in the USA.

1 reference

12 December 2020

Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers

1 reference

12 December 2020

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

12 December 2020

Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol

1 reference

12 December 2020

Is the forced swimming test a suitable model for revealing antidepressant activity?

1 reference

12 December 2020

Depression in schizophrenia: a study of prevalence and treatment

1 reference

12 December 2020

Clozaril approved for reducing risk of suicide

1 reference

12 December 2020

Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications

1 reference

12 December 2020

The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group

1 reference

12 December 2020

Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine

1 reference

12 December 2020

Can better recognition and treatment of depression reduce suicide rates? A brief review

1 reference

12 December 2020

Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects

1 reference

12 December 2020

New evidence for the antidepressant activity of MK-801, a non-competitive antagonist of NMDA receptors.

1 reference

12 December 2020

Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options

1 reference

12 December 2020

The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

1 reference

12 December 2020

Treatment of depression

1 reference

12 December 2020

Diazepam impairs acquisition but not performance in the Morris water maze.

1 reference

12 December 2020

Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study

1 reference

12 December 2020

Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist

1 reference

12 December 2020

Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice

1 reference

12 December 2020

Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization

1 reference

12 December 2020

Reconsolidation of memory after its reactivation

1 reference

12 December 2020

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol

1 reference

12 December 2020

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

1 reference

12 December 2020

Is neuroleptic dysphoria a variant of drug-induced extrapyramidal side effects?

1 reference

12 December 2020

Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine

1 reference

12 December 2020

Reversal of learned helplessness by imipramine

1 reference

12 December 2020

Failure to escape traumatic shock

1 reference

12 December 2020

The effect of monoamine oxidase inhibitors compared with classical tricyclic antidepressants on learned helplessness paradigm.

1 reference

12 December 2020

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

1 reference

12 December 2020

New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off?

1 reference

12 December 2020

Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance

1 reference

12 December 2020

Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses

1 reference

12 December 2020

Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug

1 reference

12 December 2020

Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved?

1 reference

12 December 2020

Review of quetiapine and its clinical applications in schizophrenia

1 reference

12 December 2020

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents

1 reference

12 December 2020

A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Effect of various psychotropic drugs on the performance of avoidance and escape behaviors in rats.

1 reference

12 December 2020

Seroquel: electrophysiological profile of a potential atypical antipsychotic

1 reference

12 December 2020

Haloperidol in Normals

1 reference

12 December 2020

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

1 reference

12 December 2020

A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324.

1 reference

12 December 2020

Improvement without impairment: a review of clinical data for quetiapine in the treatment of schizophrenia

1 reference

12 December 2020

Depressive symptoms in schizophrenia: comprehensive differential diagnosis

1 reference

12 December 2020

Quantitative analysis of the effects of some "atypical" and "conventional" antipsychotics on progressive ratio schedule performance

1 reference

12 December 2020

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Aripiprazole and suicidality

1 reference

12 December 2020

Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.

1 reference

12 December 2020